Why This Marine and Top MMA Fighter Was at the NYC Weed Expo

Liz Carmouche was practically on fire when I met her at the Cannabis World Congress and Business Expo (CWCBExpo) at the Javits Center in Manhattan a few weeks ago.

For those of you who don't follow mixed martial arts, she's one of the top fighters in the Ultimate Fighting Championship (UFC). She went for nearly five minutes against the legendary bantamweight Ronda Rousey in the UFC's first-ever female fight - and she won the first MMA fight ever held in the famed Madison Square Garden.

But Carmouche was not at CWCBExpo to promote her UFC career.

She was there as a promoter and proud user of products from HempMeds, a small company specializing in cannabidiol (CBD) products.

Formerly opposed to the use of any cannabis-based products, Carmouche is now a fierce advocate for CBD.

She could make a cannabis believer out of anyone. Here's what she had to say...

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Fighters of All Kinds Could Reap Benefits of Cannabis

"When you do all that wear and tear with training, you need something inevitably when the body breaks down and you need to repair and recover," Carmouche told us during an exclusive interview. "Once I started doing research and getting educated, I saw the benefits to gain without the consequences from typical medications. You take ibuprofen, and it has three benefits... and like 20 negatives."

Renegade Investment Expert: "It's time to double down - or even triple down -on your cannabis investments!" Read more...

The UFC, via the World Anti-Doping Agency, announced it would begin allowing the use of cannabis-based products last year as long as they don't have high-producing THC in them and are not in the system 10 hours before a fight. So UFC fighters can now use THC-free medical cannabis without fear of failing their pre- or post-fight "inspections."

As such, Carmouche doesn't use products with THC. She does, however, believe medical use of such products can be beneficial for veterans suffering from posttraumatic stress disorder, anxiety, and other ailments.

This is an important issue for Carmouche.

You see... she served our country.

Carmouche grew up on a military base in Japan - and went on to distinguish herself in the U.S. Marine Corps.

She's no fan of doctors prescribing these American heroes addictive opioids when they come home.

"These intense narcotics, they're just making things worse. They don't fix anything," she told us. "I used to be one of the uneducated people. I went from 'No' to saying [to fellow vets who are suffering] 'please use it.'"

Carmouche is one of many vets we met in New York last month advocating on behalf of medical cannabis rights for veterans.

Many told us their stories of how CBD-based products or even THC-containing medical marijuana has absolutely changed their lives for the better.

It was powerful stuff.

Veterans aren't alone. But they are a great "entryway" into understanding the value of medical marijuana - and the potential profits to those who take a chance and invest in the companies that make it.

I talk a lot more about medical marijuana's benefits - and how to "get in on it" - in this presentation.

Do yourself a favor and give it a look. Every time a state legalizes medical or recreational marijuana, companies see their revenue surge.

And investors see their stocks soar.

You can join them by picking the right companies at the right time. I show you how here.

Drop Everything and See This Now (There Could Be Millions of Dollars at Stake)

On June 19, Canada became the first major economy to legalize marijuana nationwide.

This means investors have a once-in-a-lifetime chance to make hundreds of thousands – if not millions – of dollars from Canadian marijuana companies.

But history is unfolding at this very moment – and even a few hours’ delay could cost you a shot at the biggest possible gains.

You need to see how to take advantage of this immediately.

Follow Money Morning on Facebook, Twitter, and LinkedIn.

About the Author

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

  • He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
  • He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
  • As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.

Read full bio